(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.75%.
Pepgen's earnings in 2026 is -$71,941,000.On average, 10 Wall Street analysts forecast PEPG's earnings for 2026 to be -$80,008,594, with the lowest PEPG earnings forecast at -$101,132,747, and the highest PEPG earnings forecast at -$69,813,593. On average, 10 Wall Street analysts forecast PEPG's earnings for 2027 to be -$85,985,690, with the lowest PEPG earnings forecast at -$145,251,059, and the highest PEPG earnings forecast at -$53,087,420.
In 2028, PEPG is forecast to generate -$77,182,806 in earnings, with the lowest earnings forecast at -$117,422,585 and the highest earnings forecast at -$58,905,219.